These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21765951)

  • 1. The expression of BAFF, APRIL and TWEAK is altered in eczema skin but not in the circulation of atopic and seborrheic eczema patients.
    Chen Y; Lind Enoksson S; Johansson C; Karlsson MA; Lundeberg L; Nilsson G; Scheynius A; Karlsson MC
    PLoS One; 2011; 6(7):e22202. PubMed ID: 21765951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas.
    Pelekanou V; Notas G; Theodoropoulou K; Kampa M; Takos D; Alexaki VI; Radojicic J; Sofras F; Tsapis A; Stathopoulos EN; Castanas E
    Anal Cell Pathol (Amst); 2011; 34(1-2):49-60. PubMed ID: 21483105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.
    Pelekanou V; Notas G; Kampa M; Tsentelierou E; Stathopoulos EN; Tsapis A; Castanas E
    PLoS One; 2013; 8(12):e83250. PubMed ID: 24376672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
    Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
    Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
    Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
    Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease.
    Nile CJ; Sherrabeh S; Ramage G; Lappin DF
    J Clin Periodontol; 2013 Sep; 40(9):875-82. PubMed ID: 23919740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
    Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
    J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura.
    Chen T; Guo ZP; Li MM; Li JY; Jiao XY; Zhang YH; Liu HJ
    Clin Exp Immunol; 2011 Oct; 166(1):64-71. PubMed ID: 21762126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 are expressed in urticarial vasculitis.
    Li M; Chen T; Guo Z; Li J; Cao N
    J Dermatol; 2013 Nov; 40(11):891-5. PubMed ID: 23968277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum APRIL levels strongly correlate with disease severity in pediatric atopic eczema.
    Mohamed Ezzat MH; Mohammed AA; Ismail RI; Shaheen KY
    Int J Dermatol; 2016 Sep; 55(9):e494-500. PubMed ID: 27061429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis.
    Zimmermann M; Koreck A; Meyer N; Basinski T; Meiler F; Simone B; Woehrl S; Moritz K; Eiwegger T; Schmid-Grendelmeier P; Kemeny L; Akdis CA
    J Allergy Clin Immunol; 2011 Jan; 127(1):200-7, 207.e1-10. PubMed ID: 21211655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of ligands belonging to tumour necrosis factor superfamily in acute lymphoblastic leukaemia.
    Bolkun L; Lemancewicz D; Jablonska E; Szumowska A; Bolkun-Skornicka U; Moniuszko M; Dzieciol J; Kloczko J
    Leuk Res; 2015 Mar; 39(3):290-5. PubMed ID: 25582383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway.
    Liu Q; Wang H; Wang X; Lu M; Tan X; Peng L; Tan F; Xiao T; Xiao S; Xia Y
    Clin Exp Immunol; 2020 Jan; 199(1):56-67. PubMed ID: 31515807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia.
    Ferrer G; Hodgson K; Pereira A; Juan M; Elena M; Colomer D; Roué G; Aymerich M; Baumann T; Montserrat E; Moreno C
    Leuk Lymphoma; 2011 Nov; 52(11):2064-8. PubMed ID: 21707303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
    Eilertsen GØ; Nossent JC
    Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.
    Bojarska-Junak A; Hus I; Chocholska S; Wasik-Szczepanek E; Sieklucka M; Dmoszyńska A; Roliński J
    Leuk Res; 2009 Oct; 33(10):1319-27. PubMed ID: 19395025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis.
    Kathamuthu GR; Moideen K; Banurekha VV; Nair D; Sridhar R; Baskaran D; Babu S
    PLoS One; 2018; 13(11):e0207404. PubMed ID: 30427928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study.
    Engh JA; Ueland T; Agartz I; Andreou D; Aukrust P; Boye B; Bøen E; Drange OK; Elvsåshagen T; Hope S; Høegh MC; Joa I; Johnsen E; Kroken RA; Lagerberg TV; Lekva T; Malt UF; Melle I; Morken G; Nærland T; Steen VM; Wedervang-Resell K; Weibell MA; Westlye LT; Djurovic S; Steen NE; Andreassen OA
    Schizophr Bull; 2022 Jan; 48(1):37-46. PubMed ID: 34499169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.